-
Je něco špatně v tomto záznamu ?
MicroRNA and Other Non-Coding RNAs in Epstein-Barr Virus-Associated Cancers
KI. Notarte, S. Senanayake, I. Macaranas, PM. Albano, L. Mundo, E. Fennell, L. Leoncini, P. Murray
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
34359809
DOI
10.3390/cancers13153909
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
EBV is a direct causative agent in around 1.5% of all cancers. The oncogenic properties of EBV are related to its ability to activate processes needed for cellular proliferation, survival, migration, and immune evasion. The EBV latency program is required for the immortalization of infected B cells and involves the expression of non-coding RNAs (ncRNAs), including viral microRNAs. These ncRNAs have different functions that contribute to virus persistence in the asymptomatic host and to the development of EBV-associated cancers. In this review, we discuss the function and potential clinical utility of EBV microRNAs and other ncRNAs in EBV-associated malignancies. This review is not intended to be comprehensive, but rather to provide examples of the importance of ncRNAs.
Department of Medical Biotechnologies Section of Pathology University of Siena 53100 Siena Italy
Faculty of Medicine and Surgery University of Santo Tomas Manila 1008 Philippines
Health Research Institute University of Limerick V94 T9PX Limerick Ireland
Institute of Immunology and Immunotherapy University of Birmingham Birmingham B15 2TT UK
Mater Misericordiae University Hospital D07AX57 Dublin Ireland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024228
- 003
- CZ-PrNML
- 005
- 20211013134017.0
- 007
- ta
- 008
- 211006s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers13153909 $2 doi
- 035 __
- $a (PubMed)34359809
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Notarte, Kin Israel $u Faculty of Medicine & Surgery, University of Santo Tomas, Manila 1008, Philippines
- 245 10
- $a MicroRNA and Other Non-Coding RNAs in Epstein-Barr Virus-Associated Cancers / $c KI. Notarte, S. Senanayake, I. Macaranas, PM. Albano, L. Mundo, E. Fennell, L. Leoncini, P. Murray
- 520 9_
- $a EBV is a direct causative agent in around 1.5% of all cancers. The oncogenic properties of EBV are related to its ability to activate processes needed for cellular proliferation, survival, migration, and immune evasion. The EBV latency program is required for the immortalization of infected B cells and involves the expression of non-coding RNAs (ncRNAs), including viral microRNAs. These ncRNAs have different functions that contribute to virus persistence in the asymptomatic host and to the development of EBV-associated cancers. In this review, we discuss the function and potential clinical utility of EBV microRNAs and other ncRNAs in EBV-associated malignancies. This review is not intended to be comprehensive, but rather to provide examples of the importance of ncRNAs.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Senanayake, Suranga $u Mater Misericordiae University Hospital, D07AX57 Dublin, Ireland
- 700 1_
- $a Macaranas, Imee $u Faculty of Medicine & Surgery, University of Santo Tomas, Manila 1008, Philippines
- 700 1_
- $a Albano, Pia Marie $u Research Center for the Natural and Applied Sciences, Molecular Diagnostics Research Group, University of Santo Tomas, Manila 1015, Philippines
- 700 1_
- $a Mundo, Lucia $u Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy $u Health Research Institute, University of Limerick, V94 T9PX Limerick, Ireland
- 700 1_
- $a Fennell, Eanna $u Health Research Institute, University of Limerick, V94 T9PX Limerick, Ireland
- 700 1_
- $a Leoncini, Lorenzo $u Department of Medical Biotechnologies, Section of Pathology, University of Siena, 53100 Siena, Italy
- 700 1_
- $a Murray, Paul $u Health Research Institute, University of Limerick, V94 T9PX Limerick, Ireland $u Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK $u Institute of Molecular and Translational Medicine, Palacký University in Olomouc, Hněvotínská 5, 779 00 Olomouc, Czech Republic
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 13, č. 15 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34359809 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20211013134015 $b ABA008
- 999 __
- $a ind $b bmc $g 1708241 $s 1144725
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 13 $c 15 $e 20210803 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- LZP __
- $a Pubmed-20211006